Tenofovir Disoproxil Fumarate and Tenofovir Alafenamide Interruption in Hepatitis B Virus/HIV Co-Infected Individuals in the USA: Monitoring Practices and Incidence of Hepatitis B Virus Reactivation or Hepatitis Flare-Reference-Cited by-同舟云学术

Tenofovir Disoproxil Fumarate and Tenofovir Alafenamide Interruption in Hepatitis B Virus/HIV Co-Infected Individuals in the USA: Monitoring Practices and Incidence of Hepatitis B Virus Reactivation or Hepatitis Flare

Published:2024-07-18 Issue: Volume: Page:40-42
ISSN:2053-4221
Container-title:EMJ Hepatology
language:
Short-container-title:EMJ Hepatol

Author:

Dieterich Douglas T.¹,Brunet Laurence²,Hsu Ricky³,Mounzer KAram⁴,Pierone Gerald⁵,Wohlfeiler Michael B.⁶,Fusco Jennifer S.²,Dunbar Megan⁷,Gruber Joshua⁷,Yee Leland J.⁸,Frenette Catherine⁹,Fusc Gregory⁹

Affiliation:

1. Institute for Liver Medicine, Mount Sinai Health System, Icahn School of Medicine at Mount Sinai, New York, USA

2. Epividian, Raleigh, North Carolina, USA

3. AIDS Healthcare Foundation, NYU Langone Medical Center, New York, USA

4. Philadelphia FIGHT, Pennsylvania, USA

5. Whole Family Health Center, Vero Beach, Florida, USA

6. AIDS Healthcare Foundation, Miami, Florida, USA

7. HIV Global Medical Affairs, Gilead Sciences, Foster City, California, USA

8. Gilead Sciences, Foster City, California, USA

9. Global Medical Affairs, Liver Diseases, Gilead Sciences, Foster City, California, USA

Funder

Gilead Sciences

Publisher

European Medical Group

Reference3 articles.

1. Terrault NA et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018;67(4):1560-99.

2. Clinicalinfo. Panel on Antiretroviral Guidelines for Adults and Adolescents, Department of Health and Human Services. Guidelines for the use of antiretroviral agents in adults and adolescents with HIV 2024. Available at: https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/whats-new. Last accessed: 14 June 2024

3. Centers for Disease Control and Prevention (CDC). HIV Surveillance Report, 2021. 2023. Available at: https://stacks.cdc.gov/view/cdc/149071. Last accessed: 31 May 2023.